Advertisement

Topics

Copernicus Therapeutics, Inc. Company Profile

18:58 EDT 24th September 2017 | BioPortfolio

Copernicus' Management and Board of Directors have experience in company management, pharmaceutical/biotechnology R&D, clinical development, and finance.

Location

11000 Cedar Avenue, Suite 145
Cleveland
Ohio
44106-3052
United States of America

Contact

Phone: 216-231-0227
Fax: 216-231-9477
Email: jcandela@cgsys.com


News Articles [1536 Associated News Articles listed on BioPortfolio]

WIRB-Copernicus Group acquires MedAvante and ProPhase

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, has acquired MedAvante and ProPhase, and has named Dr. Jeffrey Litwin as ...

WIRB-Copernicus Group acquires eConsent tech

WIRB-Copernicus Group (WCG) has acquired eConsent technology to help clinical trial volunteers – and their families – make more informed decisions, says CEO.

WIRB-Copernicus Group acquires FDAnews

WIRB-Copernicus Group (WCG), a provider of solutions to measurably improve the quality and efficiency of clinical research, has acquired FDAnews, which provides global regulatory information for execu...

WIRB-Copernicus Group acquires Patient Genesis’ ConsentNow eConsent Technology

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, has acquired Patient Genesis’ ConsentNow eConsent technology. ConsentNo...

WIRB-Copernicus Group, inVentiv Health, National Institutes of Health, And More: News From July 2017

Clinical Informatics News Brief | News, products, and partnerships from around the clinical trial and healthcare community including news from WIRB-Copernicus Group, inVentiv Health, National Institut...

FDAnews Joins WIRB-Copernicus Group

  Life Sciences Jobs   ...

WIRB-Copernicus Group (WCG) Celebrates IBC Review Milestone

  Life Sciences Jobs   ...

WIRB-Copernicus Group Acquires MedAvante And Prophase

  Life Sciences Jobs   ...

Clinical Trials [118 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1147 Associated Companies listed on BioPortfolio]

Copernicus Therapeutics Incorporated

Copernicus Therapeutics, Inc. is a privately-held company developing products for human gene therapy and vaccination. Copernicus was established in 1997 based on technologies discovered at Case Wester...

Copernicus Therapeutics, Inc.

Copernicus' Management and Board of Directors have experience in company management, pharmaceutical/biotechnology R&D, clinical development, and finance.

Copernicus Group IRB

Copernicus Group IRB was established in July 1996 as an independent institutional review board (IRB or "Board") and operates in compliance with Federal Regulations governing institutional review board...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Copernicus Therapeutics, Inc." on BioPortfolio

We have published hundreds of Copernicus Therapeutics, Inc. news stories on BioPortfolio along with dozens of Copernicus Therapeutics, Inc. Clinical Trials and PubMed Articles about Copernicus Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Copernicus Therapeutics, Inc. Companies in our database. You can also find out about relevant Copernicus Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record